• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自海水鱼链球菌病爆发的海豚链球菌和格氏乳球菌的细菌幽灵疫苗,可诱导尼罗罗非鱼(Oreochromis niloticus,林奈,1758)对该病产生潜在保护作用。

Vaccination with bacterial ghosts of Streptococcus iniae and Lactococcus garvieae originated from outbreak of marine fish streptococcosis, induce potential protection against the disease in Nile tilapia, Oreochromis niloticus (Linnaeus, 1758).

作者信息

Hussein Mortada M A, Hassan Walid H, Yassen Hosam A, Osman Ahmed M A

机构信息

Fish Diseases and Management Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, 62513, Egypt.

Bacteriology, Mycology and Immunology Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, 62513, Egypt.

出版信息

Fish Shellfish Immunol. 2023 Oct;141:109008. doi: 10.1016/j.fsi.2023.109008. Epub 2023 Aug 19.

DOI:10.1016/j.fsi.2023.109008
PMID:37604267
Abstract

Streptococcosis is an important bacterial disease affects fresh, brackish and marine fish. The disease caused annual severe economic losses in Egyptian Mari-culture. S. iniae and L. garvieae usually the main causative agents isolated. The presented study conducted to prepare bacterial ghost vaccine (BGV) candidates from isolated strains of marine streptococcosis outbreaks using NaOH chemical approach. Selected strains confirmed as pathogenic for Nile tilapia, therefore the fish selected as an experimental model. In such respect, the re-isolated S. iniae and L. garvieae were used for ghost preparations, BGVs evaluation and fish challenges. Apart of four, three fish groups namely, A, B, C designated for BGVs evaluations, while the fourth one (D) designated as control. Vaccination experiments performed via intra-peritoneal injection with 0.1 mL (1.5 × 10 CFU/mL/fish) of their corresponding BGVs twice with 2 weeks' interval; however, control fish received 0.1 mL of fish saline instead. Blood, serum, and tissue samples collected from all groups at 2 and 4 weeks post immunization (PI) for estimation of hematological, innate, and specific immune parameters. At the end, all remained fish challenged with appropriated pathogen (s) and the relative percentage of survival (RPS) calculated. Three BGVs generated namely, SiG, in addition to, novel contributions of LgG and SiLgG. Ghosts were corresponding to S. iniae, L. garvieae and their both ghost mixtures, respectively. Fish groups immunized with prepared BGVs revealed variable significant increases in PCV, GLB, PP, SOD, CAT, C5, IL-β1, LZM, specific antibody titers and CD4 expression 2 and 4 weeks PI. MDA decreased in all vaccinated groups that was significantly with group C. Expression of MHC-II showed elevations 2 weeks PI, however, it significantly decreased at 4 weeks. The RPS recorded 90, 88.89 and 95.46% in immunized groups A, B and C, respectively. At all levels tested, obtained results proposed SiG, LgG and SiLgG as innovative vaccine candidates, which can protect cultured fish from being attacked by S. iniae, and/or L. garvieae.

摘要

链球菌病是一种影响淡水、咸淡水和海水鱼类的重要细菌性疾病。该病在埃及海水养殖中每年造成严重的经济损失。海豚链球菌和加氏乳球菌通常是分离出的主要病原体。本研究采用氢氧化钠化学方法,从海洋链球菌病暴发的分离菌株中制备细菌幽灵疫苗(BGV)候选物。选定的菌株被确认为对尼罗罗非鱼具有致病性,因此选择该鱼作为实验模型。在这方面,重新分离的海豚链球菌和加氏乳球菌用于制备幽灵、评估BGV和对鱼进行攻毒试验。除了四组鱼外,将三组鱼分别命名为A、B、C组用于评估BGV,而第四组(D组)作为对照组。通过腹腔注射0.1 mL(1.5×10 CFU/mL/鱼)相应的BGV进行疫苗接种实验,间隔2周注射两次;然而,对照鱼注射0.1 mL鱼生理盐水。在免疫后(PI)2周和4周从所有组采集血液、血清和组织样本,以评估血液学、先天性和特异性免疫参数。最后,用相应病原体对所有剩余的鱼进行攻毒,并计算相对存活率(RPS)。制备了三种BGV,即SiG,此外还有新型的LgG和SiLgG。幽灵分别对应海豚链球菌、加氏乳球菌及其两者的幽灵混合物。用制备的BGV免疫的鱼组在免疫后2周和4周时,红细胞压积(PCV)、球蛋白(GLB)、血小板(PP)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、补体5(C5)、白细胞介素-β1(IL-β1)、溶菌酶(LZM)、特异性抗体滴度和CD4表达均有不同程度的显著增加。所有接种组的丙二醛(MDA)均下降,C组下降显著。主要组织相容性复合体II类(MHC-II)的表达在免疫后2周升高,但在4周时显著下降。免疫组A、B和C的RPS分别为90%、88.89%和95.46%。在所有测试水平上,获得的结果表明SiG、LgG和SiLgG是创新的疫苗候选物,可保护养殖鱼类免受海豚链球菌和/或加氏乳球菌的攻击。

相似文献

1
Vaccination with bacterial ghosts of Streptococcus iniae and Lactococcus garvieae originated from outbreak of marine fish streptococcosis, induce potential protection against the disease in Nile tilapia, Oreochromis niloticus (Linnaeus, 1758).源自海水鱼链球菌病爆发的海豚链球菌和格氏乳球菌的细菌幽灵疫苗,可诱导尼罗罗非鱼(Oreochromis niloticus,林奈,1758)对该病产生潜在保护作用。
Fish Shellfish Immunol. 2023 Oct;141:109008. doi: 10.1016/j.fsi.2023.109008. Epub 2023 Aug 19.
2
Efficacy of a Eudragit L30D-55 encapsulated oral vaccine containing inactivated bacteria (Lactococcus garvieae/Streptococcus iniae) in rainbow trout (Oncorhynchus mykiss).含包被灭活菌(迟缓爱德华氏菌/无乳链球菌)的 Eudragit L30D-55 胶囊口服疫苗对虹鳟(Oncorhynchus mykiss)的功效。
Fish Shellfish Immunol. 2018 Oct;81:430-437. doi: 10.1016/j.fsi.2018.07.048. Epub 2018 Jul 26.
3
Valuable method for production of oral vaccine by using alginate and chitosan against Lactococcus garvieae/Streptococcus iniae in rainbow trout (Oncorhynchus mykiss).利用海藻酸钠和壳聚糖生产抗鳗弧菌/无乳链球菌口服疫苗的有效方法在虹鳟鱼(Oncorhynchus mykiss)中的应用。
Fish Shellfish Immunol. 2019 Jul;90:431-439. doi: 10.1016/j.fsi.2019.05.020. Epub 2019 May 11.
4
High efficacy and economical procedure of oral vaccination against Lactococcus garvieae/Streptococcus iniae in rainbow trout (Oncorhynchus mykiss).口服疫苗对虹鳟鱼(Oncorhynchus mykiss)中腐败希瓦氏菌/无乳链球菌的高效经济预防程序。
Fish Shellfish Immunol. 2020 Apr;99:505-513. doi: 10.1016/j.fsi.2020.02.033. Epub 2020 Feb 22.
5
Immuno-protective efficiency of feed-based whole-cell inactivated bivalent vaccine against Streptococcus and Aeromonas infections in red hybrid tilapia (Oreochromis niloticus × Oreochromis mossambicus).基于饲料的双联全细胞灭活疫苗对奥利亚罗非鱼(尼罗罗非鱼×莫桑比克罗非鱼)链球菌和气单胞菌感染的免疫保护效率。
Fish Shellfish Immunol. 2021 Jun;113:162-175. doi: 10.1016/j.fsi.2021.04.006. Epub 2021 Apr 12.
6
Haemato-immunological responses and effectiveness of feed-based bivalent vaccine against Streptococcus iniae and Aeromonas hydrophila infections in hybrid red tilapia (Oreochromis mossambicus × O. niloticus).血免疫反应和基于饲料的双价疫苗对杂交红罗非鱼(奥利亚罗非鱼×尼罗罗非鱼)链球菌和嗜水气单胞菌感染的效果。
BMC Vet Res. 2020 Jul 2;16(1):226. doi: 10.1186/s12917-020-02443-y.
7
Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus).新型盐酸金霉素抗性鮰鱼链球菌的研制及其在尼罗罗非鱼(Oreochromis niloticus)中的免疫效力。
Vaccine. 2011 Aug 11;29(35):5986-93. doi: 10.1016/j.vaccine.2011.06.036. Epub 2011 Jun 25.
8
Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.经哈维氏弧菌疫苗和无乳链球菌疫苗免疫尼罗罗非鱼的交叉免疫。
Fish Shellfish Immunol. 2020 Feb;97:382-389. doi: 10.1016/j.fsi.2019.12.021. Epub 2019 Dec 10.
9
Duration of Protection and Humoral Immune Response in Nile Tilapia ( L.) Vaccinated against .尼罗罗非鱼(L.)接种针对……的疫苗后的保护持续时间和体液免疫反应
Animals (Basel). 2024 Jun 9;14(12):1744. doi: 10.3390/ani14121744.
10
Immunization with bacterial antigens: infections with streptococci and related organisms.用细菌抗原进行免疫接种:链球菌及相关生物体感染
Dev Biol Stand. 1997;90:153-60.

引用本文的文献

1
Antigenic Protein Screening and Design of Multi-Epitope Vaccine Against Lactococcus garvieri and Streptococcus iniae for Combating Lactococcosis and Streptococcosis in Fish.抗加氏乳球菌和海豚链球菌的多表位疫苗抗原蛋白筛选及设计以防治鱼类乳球菌病和链球菌病
Vet Med Sci. 2025 Jul;11(4):e70465. doi: 10.1002/vms3.70465.
2
A New Strategy to Prevent Emerging Infections by Using Organic Acids as Antimicrobials In Vitro and Ex Vivo.一种通过使用有机酸作为体外和体内抗菌剂来预防新出现感染的新策略。
Int J Mol Sci. 2025 Apr 5;26(7):3423. doi: 10.3390/ijms26073423.